The store will not work correctly when cookies are disabled.
5,7-difluoro-2-methyl-3-undecyl-1H-quinolin-4-one
ID: ALA4529042
PubChem CID: 67016340
Max Phase: Preclinical
Molecular Formula: C21H29F2NO
Molecular Weight: 349.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCCCCCc1c(C)[nH]c2cc(F)cc(F)c2c1=O
Standard InChI: InChI=1S/C21H29F2NO/c1-3-4-5-6-7-8-9-10-11-12-17-15(2)24-19-14-16(22)13-18(23)20(19)21(17)25/h13-14H,3-12H2,1-2H3,(H,24,25)
Standard InChI Key: KEQGBWOWJDYGAQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
32.6898 -4.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3975 -4.0613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1053 -4.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1053 -5.2879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3975 -5.6996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6898 -5.2879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9806 -5.6971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2725 -5.2898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2699 -4.4724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9776 -4.0592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9776 -3.2404 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.5650 -5.6971 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.8127 -5.6994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8127 -4.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5243 -4.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2317 -4.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9392 -4.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6507 -4.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3582 -4.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0656 -4.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7730 -4.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4846 -4.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1920 -4.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8995 -4.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3975 -3.2426 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 1 0
1 6 2 0
6 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
1 10 1 0
10 11 1 0
8 12 1 0
4 13 1 0
3 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
2 25 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 349.47 | Molecular Weight (Monoisotopic): 349.2217 | AlogP: 6.19 | #Rotatable Bonds: 10 |
Polar Surface Area: 32.86 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 7.28 | CX LogD: 7.28 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.51 | Np Likeness Score: -0.31 |
References
1. Deng Y, Wu T, Zhai SQ, Li CH.. (2019) Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening., 183 [PMID:31585276] [10.1016/j.ejmech.2019.111711] |
2. Wu RZ, Zhou HY, Song JF, Xia QH, Hu W, Mou XD, Li X.. (2021) Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations., 64 (24.0): [PMID:34894691] [10.1021/acs.jmedchem.1c01569] |